23andMe Expands DNA Data Mining Amid Business Challenges
23andMe Faces Uncertain Future Amid Strategic Shift Genetic testing company 23andMe is undergoing a significant transformation in response to a drop in demand and a tarnished reputation stemming from a data breach. The company’s stock is currently struggling, with the possibility of being removed from the Nasdaq looming. CEO Anne Wojcicki is striving to reassure…